Subsequent catabolic effects and the impact on energy balance in terms of orexigenic signaling (e.g., via neuropeptide Y, NPY) further contribute to the maintenance of obesity and its comorbidities (Strack et al., 1995; Chrousos, 2009). Here, NPY is linked to obesity disorder.